Home » Stocks » NPTX » Statistics

Neuropathix, Inc (NPTX)

Stock Price: $0.1299 USD -0.0001 (-0.08%)
Updated Jun 23, 2021 3:09 PM EDT - Market closed

Total Valuation

Neuropathix has a market cap or net worth of $11.44 million. The enterprise value is $12.81 million.

Market Cap 11.44M
Enterprise Value 12.81M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Neuropathix has 87.98 million shares outstanding. The number of shares has increased by 18.53% in one year.

Shares Outstanding 87.98M
Share Change (YoY) +18.53%
Share Change (QoQ) +17.90%
Owned by Insiders (%) 66.84%
Owned by Institutions (%) n/a
Float 27.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 357.41
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings n/a
EV / Sales 400.25
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio 0.17
Quick Ratio 0.16
Debt / Equity n/a
Debt / EBITDA -0.36
Debt / FCF -1.61

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -893.16%
Return on Capital (ROIC) 829.40%
Revenue Per Employee $4,571
Profits Per Employee -$794,002
Employee Count 7
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a
Taxes as % of Revenue n/a

Stock Price Statistics

The stock price has decreased by -88.18% in the last 52 weeks. The beta is 1.67, so Neuropathix's price volatility has been higher than the market average.

Beta (1Y) 1.67
52-Week Price Change -88.18%
50-Day Moving Average 0.14
200-Day Moving Average 0.18
Average Volume (30 Days) 16,877

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Neuropathix had revenue of $32,000 and -$5.56 million in losses. Earnings per share was -$0.08.

Revenue 32,000
Gross Profit 32,000
Operating Income -5.17M
Net Income -5.56M
EBIT -4.71M
Earnings Per Share (EPS) -$0.08
Full Income Statement

Balance Sheet

The company has $323,190 in cash and $1.69 million in debt, giving a net cash position of -$1.37 million or -$0.02 per share.

Cash & Cash Equivalents 323,190
Total Debt 1.69M
Net Cash -1.37M
Net Cash Per Share -$0.02
Book Value -2.74M
Book Value Per Share -0.03
Working Capital -2.02M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.04 million and capital expenditures -$8,100, giving a free cash flow of -$1.05 million.

Operating Cash Flow -1.04M
Capital Expenditures -8,100
Free Cash Flow -1.05M
FCF Per Share -$0.01
Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -16,167.91% and -17,368.80%.

Gross Margin 100.00%
Operating Margin -16,167.91%
Profit Margin -17,368.80%
EBITDA Margin -14,680.89%
EBIT Margin -14,732.60%
FCF Margin -3,278.45%

Dividends & Yields

Neuropathix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -48.60%
FCF Yield -9.17%
Dividend Growth (YoY) n/a
Payout Ratio n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a